Chondroitin sulfate is a naturally occurring glycosaminoglycan found in cartilage. It is widely used in dietary supplements, pharmaceuticals, and veterinary medicine-primarily for joint health support and osteoarthritis management. For procurement teams, understanding the supply landscape is essential as global demand continues to rise with aging populations.
What are some chondroitin sulfate manufacturers?
Global production is heavily concentrated in China. Key manufacturers include SANXIN (China), WanTuMing Biological (China), TSI Group (USA), Yantai Dongcheng Pharmaceutical Group (China), Focus Chem (China), YBCC (China), Runxin Biotechnology (China), ISBA (China), Huiwen (China), and QJBCHINA (China). Yantai Dongcheng Biochemicals, through its acquisition of Sino Siam Biotechnique Co., Ltd. in Thailand, has positioned itself as the world's largest supplier of chondroitin sulfate. Merck KGaA led the global market with over 16.9% share in 2025, while the top five players collectively held 46% of the market.
Which chondroitin sulfate manufacturers are good?
In B2B sourcing, "good" means consistent purity, regulatory compliance, and reliable supply. Yantai Dongcheng was the first domestic Chinese manufacturer to pass USP certification in the United States. SANXIN and WanTuMing Biological are leading Chinese producers with substantial export volumes. TSI Group represents a key non-Chinese supplier with strong global distribution.
Top 10 manufacturers of chondroitin sulfate in China
Leading Chinese manufacturers include SANXIN, WanTuMing Biological, Yantai Dongcheng Pharmaceutical Group, Focus Chem, YBCC, Runxin Biotechnology, Jiaxing Hengjie Biopharmaceutical, Meitek, Shandong AWA Biopharm, and Huiwen.
Top 10 suppliers of chondroitin sulfate in China
Key Chinese suppliers include SANXIN, WanTuMing Biological, Yantai Dongcheng Biochemicals, Focus Chem, YBCC, Runxin Biotechnology, Xi'an Lyphar Biotech, Shaanxi Guanjie Technology, Wuhan Vanz Pharm, and Foodchem International.
Market data
The global chondroitin sulfate market was valued at approximately USD 1.2-1.5 billion in 2025, with growth projections varying by source and application. The overall market is projected to grow at a CAGR of approximately 4-8%, driven primarily by the dietary supplement and pharmaceutical-grade segments. According to the World Health Organization, osteoarthritis affects over 240 million people worldwide, with the number of people aged 60 and older expected to double by 2050 to over 2 billion-creating sustained demand for joint health supplements including chondroitin sulfate. China accounts for over 75% of the global chondroitin sulfate market, and approximately 60% of Chinese exports are destined for the United States. The global top five manufacturers together hold approximately 25% of market share, reflecting a more fragmented competitive landscape compared to other ingredient categories. Key demand drivers include the aging global population, increasing prevalence of osteoarthritis, growing consumer preference for nutraceuticals over pharmaceuticals for joint health, pet supplement market expansion, and shifting interest toward microbial fermentation-derived and plant-based production to address sustainability concerns.
About Jeci Biochemical
At Hangzhou Jeci Biochemical Technology Co., Ltd., we supply high-quality Chondroitin Sulfate alongside a comprehensive portfolio of APIs, intermediates, and nutritional ingredients. With GMP, ISO, Kosher, Halal, HACCP, NSF, and FAMI-QS certifications, we support clients worldwide with reliable, large-scale supply and rigorous quality management.
Is Chondroitin Sulfate on your sourcing radar? Let's connect.
